Clinical Trials Logo

Primary Antibody Deficiency clinical trials

View clinical trials related to Primary Antibody Deficiency.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02247141 Completed - Clinical trials for Primary Antibody Deficiency

A Multi-centre Open Study to Assess the Safety and Efficacy of Subgam®

Start date: June 2000
Phase: Phase 3
Study type: Interventional

The primary objective was to determine the efficacy of Human Normal Immunoglobulin (Subgam®) given subcutaneously by weekly infusion to patients with primary antibody deficiency. The secondary objective was to determine the safety of Subgam® given subcutaneously by weekly infusion to patients with primary antibody deficiency.